Product NDC: | 55390-162 |
Proprietary Name: | Octreotide Acetate |
Non Proprietary Name: | Octreotide Acetate |
Active Ingredient(s): | 500 ug/mL & nbsp; Octreotide Acetate |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-162 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076313 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050404 |
Package NDC: | 55390-162-10 |
Package Description: | 10 VIAL in 1 BOX (55390-162-10) > 1 mL in 1 VIAL |
NDC Code | 55390-162-10 |
Proprietary Name | Octreotide Acetate |
Package Description | 10 VIAL in 1 BOX (55390-162-10) > 1 mL in 1 VIAL |
Product NDC | 55390-162 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Octreotide Acetate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20050404 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | OCTREOTIDE ACETATE |
Strength Number | 500 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |